The presence of the driver EML4 –ALK fusion also identifies a category of NSCLC patients who are characterized clinicopathologically by relatively younger age, non-smokers or light smokers, and a mucinous, cribriform or signet–ring cell subtype of adenocarcinoma [5–7]. Here, ALK is linked to non-small cell lung carcinoma.